Modifies provisions relating to the ordering and administration of vaccines by pharmacists
Summary
HB 1976 revises Missouri’s pharmacy practice statute to expand and clarify what pharmacists may do, with a particular focus on vaccine ordering and administration. The bill repeals and reenacts section 338.010 to define the “practice of pharmacy” to include administering FDA-approved or authorized vaccines, along with related duties such as prescription handling, medication therapy management, nicotine replacement therapy, and HIV postexposure prophylaxis. It also sets out conditions for pharmacist vaccine administration, including age thresholds, CDC-based treatment guidelines, required training, observation for adverse reactions, emergency protocols, and reporting vaccinations to the state’s ShowMeVax system or, if the patient opts out, to the patient’s health care provider.
Impact
The bill would amend Missouri law governing pharmacists by expressly authorizing vaccine ordering and administration under specified protocols and by updating the statutory definition of pharmacy practice. It would preserve limits on pharmacist authority by excluding certain vaccines, requiring joint rulemaking by the Board of Pharmacy and the State Board of Registration for the Healing Arts, and stating that pharmacists may not independently diagnose or prescribe pharmaceuticals. The measure also affects physician-pharmacist protocol relationships, medication therapeutic plan authority, and reporting requirements tied to immunization records and public health emergency response.
Sentiment
The available record shows no committee transcript or recorded votes, so there is no direct evidence of debate or formal support/opposition in the materials provided. Based on the bill text, the overall policy direction appears supportive of expanded pharmacist participation in preventive care and vaccine access, while retaining medical oversight and regulatory safeguards. The bill’s referral to the Emerging Issues Committee suggests it was treated as a policy update with health-care practice implications.
Contention
The main points of contention likely center on the scope of pharmacist authority and the degree of physician oversight. The bill limits pharmacist action by excluding certain vaccines, requiring written physician protocols for medication therapy services, and prohibiting independent diagnosis or prescribing, which may reflect concerns from physicians or other health professionals about scope of practice. Additional potential friction points include the mandatory reporting of vaccinations to ShowMeVax, the patient opt-out process, and the requirement that rulemaking be jointly approved by both the pharmacy and healing arts boards.